시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 세보플루란 마취제 시장 인사이트, 예측(-2030년)
Global Sevoflurane Anesthesia Drugs Market Insights, Forecast to 2030
상품코드 : 1559190
리서치사 : QYResearch
발행일 : 2024년 09월
페이지 정보 : 영문
 라이선스 & 가격 (부가세 별도)
US $ 4,900 ￦ 7,017,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,350 ￦ 10,526,000
PDF (Multi User License) help
PDF, Excel 보고서를 동일 기업내 10명까지 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.
US $ 9,800 ￦ 14,035,000
PDF (Enterprise User License) help
PDF, Excel, Word 보고서를 동일 기업내 모든 구성원이 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 세보플루란 마취제 시장 규모는 2024년 12억 6,203만 달러에서 2030년까지 16억 1,253만 달러에 달할 것으로 예측되며, 예측 기간에 CAGR로 4.17%의 성장이 전망됩니다.

미국·캐나다 시장 규모는 2024년 3억 1,013만 달러에서 2030년까지 3억 7,962만 달러에 달할 것으로 추정되며, 2024-2030년의 예측 기간의 CAGR은 3.43%입니다.

중국 시장 규모는 2024년 5억 2,587만 달러에서 2030년까지 7억 644만 달러에 달할 것으로 추정되며, 예측 기간의 CAGR은 5.04%입니다.

세계의 세보플루란 마취제의 주요 제조업체는 Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma 등입니다. 2023년, 세계의 상위 5사의 매출 점유율은 약 91.92%였습니다.

세계의 세보플루란 마취제 시장에 대해 조사분석했으며, 판매, 매출, 시장 점유율, 주요 제조업체 순위 등의 정보를 제공하고 있습니다.

목차

제1장 조사 범위

제2장 개요

제3장 각 제조업체의 경쟁

제4장 시장 규모 : 유형별

제5장 시장 규모 : 용도별

제6장 북미

제7장 유럽

제8장 중국

제9장 아시아(중국 이외)

제10장 중동 및 아프리카·라틴아메리카

제11장 기업 개요

제12장 산업 체인과 판매채널 분석

제13장 세보플루란 마취제 시장 역학

제14장 세계의 세보플루란 마취제 연구의 주요 조사 결과

제15장 부록

KSA
영문 목차

영문목차

The global Sevoflurane Anesthesia Drugs market is projected to grow from US$ 1262.03 million in 2024 to US$ 1612.53 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.17% during the forecast period.

The United States & Canada market for Sevoflurane Anesthesia Drugs is estimated to increase from $ 310.13 million in 2024 to reach $ 379.62 million by 2030, at a CAGR of 3.43% during the forecast period of 2024 through 2030.

The China market for Sevoflurane Anesthesia Drugs is estimated to increase from $ 525.87 million in 2024 to reach $ 706.44 million by 2030, at a CAGR of 5.04% during the forecast period of 2024 through 2030.

The global key manufacturers of Sevoflurane Anesthesia Drugs include Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, etc. In 2023, the global top five players had a share approximately 91.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Sevoflurane Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sevoflurane Anesthesia Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sevoflurane Anesthesia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sevoflurane Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sevoflurane Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sevoflurane Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, etc.

Market Segmentation

By Company

Segment by Type

Segment by Application

Segment by Region

North America

China

Asia (Ex. China)

Europe

Middle East, Africa, Latin America

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Sevoflurane Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Sevoflurane Anesthesia Drugs manufacturer's competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (Ex. China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

2 EXECUTIVE SUMMARY

3 COMPETITION BY MANUFACTURERS

4 MARKET SIZE BY TYPE

5 MARKET SIZE BY APPLICATION

6 NORTH AMERICA

7 EUROPE

8 CHINA

9 ASIA (EX. CHINA)

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

11 CORPORATE PROFILE

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13 SEVOFLURANE ANESTHESIA DRUGS MARKET DYNAMICS

14 KEY FINDINGS IN THE GLOBAL SEVOFLURANE ANESTHESIA DRUGS STUDY

15 APPENDIX

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기